{"id":48,"date":"2023-12-11T09:45:00","date_gmt":"2023-12-11T09:45:00","guid":{"rendered":"https:\/\/eua25.org\/?page_id=48"},"modified":"2025-05-17T10:23:36","modified_gmt":"2025-05-17T10:23:36","slug":"bilimsel-program","status":"publish","type":"page","link":"https:\/\/eua25.org\/en\/bilimsel-program\/","title":{"rendered":"Scientific Programme"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"48\" class=\"elementor elementor-48\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-621c259 e-con-full e-flex e-con e-parent\" data-id=\"621c259\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2bd6c6e e-n-tabs-mobile elementor-widget elementor-widget-n-tabs\" data-id=\"2bd6c6e\" data-element_type=\"widget\" data-settings=\"{&quot;horizontal_scroll&quot;:&quot;disable&quot;}\" data-widget_type=\"nested-tabs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"e-n-tabs\" data-widget-number=\"45968494\" aria-label=\"Tabs. Open items with Enter or Space, close with Escape and navigate using the Arrow keys.\">\n\t\t\t<div class=\"e-n-tabs-heading\" role=\"tablist\">\n\t\t\t\t\t<button id=\"e-n-tab-title-459684941\" class=\"e-n-tab-title\" aria-selected=\"true\" data-tab-index=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"e-n-tab-content-459684941\" style=\"--n-tabs-title-order: 1;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t16 May 2025 - Friday\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-459684942\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-459684942\" style=\"--n-tabs-title-order: 2;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t17 May 2025 - Saturday \t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-459684943\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-459684943\" style=\"--n-tabs-title-order: 3;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t18 May 2025 - Sunday\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-459684944\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-459684944\" style=\"--n-tabs-title-order: 4;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\t19 May 2025 - Monday\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t\t<\/div>\n\t\t\t<div class=\"e-n-tabs-content\">\n\t\t\t\t<div id=\"e-n-tab-content-459684941\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-459684941\" data-tab-index=\"1\" style=\"--n-tabs-title-order: 1;\" class=\"e-active elementor-element elementor-element-3b2002e e-con-full e-flex e-con e-child\" data-id=\"3b2002e\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5e0de8a elementor-widget elementor-widget-html\" data-id=\"5e0de8a\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div style=\"overflow: auto\">\r\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" class=\"program\">\r\n  <col width=\"15%\">\r\n  <col width=\"85%\">\r\n  <tr>\r\n    <th colspan=\"2\"><strong>16 May 2025 - Friday<\/strong><\/th>\r\n  <\/tr>\r\n \r\n  <tr class=\"halla\">\r\n    <td>&nbsp;<\/td>\r\n    <td>HALL A<\/td>\r\n  <\/tr>\r\n  <tr class=\"session\">\r\n    <td><strong>13.00  - 15.00<\/strong><\/td>\r\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Prostate  cancer screening and diagnosis <\/strong><br>\r\nModerators:<strong><em>Ali \u0130hsan Ta\u015f\u00e7\u0131, B\u00fclent G\u00fcnl\u00fcsoy, Hasan  Bak\u0131rta\u015f<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>13.00 -  13.15<\/td>\r\n    <td>Current  evidence and ongoing projects in screening programmes (OPT trial, PROBASE  trial, TRANSFORM trial, PRAISE-U) \/ <strong><em>Murat Bozlu<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>13.15  -13.30<\/td>\r\n    <td>Prostate  micro ultrasound \/ <strong><em>Massimo Lazzeri <i class=\"fas fa-wifi\"><\/i><\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>13.30  - 13.45<\/td>\r\n    <td>Targeted  + Perilesional prostate biopsy: Is it a new approach to hit the bullseye? \/ <strong><em>Mehmet \u00c7a\u011flar \u00c7ak\u0131c\u0131<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>13.45  -14.00<\/td>\r\n    <td>Fundamentals  in biparametric vs multiparametric mpMRI imaging for local diagnosis and  staging \/ <strong><em>R\u00fc\u015ft\u00fc T\u00fcrkay<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td >14.00  - 14.15<\/td>\r\n    <td>Limits  of active surveillance in prostate cancer and the effect of imaging on active  surveillance \/ <strong><em>As\u0131f Y\u0131ld\u0131r\u0131m<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td >14.15  - 14.30<\/td>\r\n    <td>Focal  Therapies<em><strong> \/ <\/strong><\/em><strong>\u00d6ztu\u011f Adsan<\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td >14.30  - 15.00<\/td>\r\n    <td><strong>Round Table  (Prostate cancer localise disease)<\/strong><br>\r\n      Moderator:<strong> <em>B\u00fclent Akduman<\/em><\/strong><br>\r\n      (Case  presentation: 52 yrs, PIRADS-4, MCCL &lt; 6mm ISUP 2, 10% GP4, BRCA2 +)<br>\r\n      <em><strong>\u00d6zcan  Y\u0131ld\u0131z, Nil\u00fcfer Duranku\u015f, Sinan Kire\u00e7\u00e7i, Nesrin G\u00fcnd\u00fcz,  Tolga Karakan<\/strong><\/em><\/td>\r\n  <\/tr>\r\n  \r\n  <tr class=\"break\">\r\n    <td>15.00  - 15.15<\/td>\r\n    <td>Coffee Break<\/td>\r\n  <\/tr>\r\n \r\n  <tr class=\"session\">\r\n    <td><strong>15.15  - 17.05<\/strong><\/td>\r\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Prostate  cancer high risk disease and locale advanced disease\u00a0 <\/strong><br>\r\n      Moderators:&nbsp;<strong><em>Abdurrahim \u0130mamoglu, Bilal Eryildirim, Mehmet Kutlu Demirkol<\/em><\/strong> <\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>15.15  - 15.30<\/td>\r\n    <td>Radical  prostatectomy (Retzius sparing - Pelvic fascia sparing - How to avoid positive  margins during nerve-sparing) \/<em> <strong>Antonio Galfano <i class=\"fas fa-wifi\"><\/i><\/strong><\/em><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>15.30  - 15.50<\/td>\r\n    <td>Can PET  PSMA spare extended pelvic lymph node dissection?<br>\r\n      Yes ? <strong><em>Selcuk Sahin<\/em><\/strong><br>\r\n      No ? <strong><em>Meftun Culpan<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>15.50  - 16.05<\/td>\r\n    <td>Radiotherapy  for prostate cancer \/ <strong><em>Eseng\u00fcl Ko\u00e7ak <i class=\"fas fa-wifi\"><\/i><\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr class=\"uydu-alt\">\r\n    <td>16.05 - 16.35<\/td>\r\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/Aymed-Logo.jpg\" alt=\"\" width=\"150\"  height=\"65\" align=\"right\"\/>Satellite Symposium<\/strong> <br>\r\n     <strong>Phytotherapy in Urologic Cancers <\/strong><br>\r\n      Moderator: <strong><em>Derya Balbay<br>\r\n      <\/em><\/strong>Panelist: <strong><em>\u00d6mer K\u00fc\u00e7\u00fck <\/em><i class=\"fas fa-wifi\"><\/i><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>16.35  - 17.05<\/td>\r\n    <td><strong>CASE  PRESENTATION \u2013 Patients with high risk and locale advanced prostate cancer<\/strong><br>\r\n      Moderator:<strong> <em>Sak\u0131p Erturhan <\/em><\/strong><br>\r\n      <strong>Panelist:  <em>Selahattin Bedir, Mahmut G\u00fcm\u00fc\u015f, Didem  Karacetin<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr class=\"session\">\r\n    <td><strong>17.05  - 18.05<\/strong><\/td>\r\n    <td><strong>Semi-live  (Video) Section (Prostate Cancer)<\/strong><br>\r\n      <strong>Moderator:  <em>Erdal Apayd\u0131n, Sacit Nuri G\u00f6rgel<\/em><\/strong><\/td>\r\n    <\/tr>\r\n  <tr>\r\n    <td>&nbsp;<\/td>\r\n    <td><strong>Case 1: <\/strong>Robotic radical prostatectomy in the large prostate  \/ <strong><em>C\u00fcneyt \u00d6zden<\/em><\/strong><br>\r\n      <strong>Case 2: <\/strong>Perineal prostatectomy \/<em> <strong>Selami Albayrak<\/strong><\/em><br>\r\n      <strong>Case 3: <\/strong>Robotic prostatectomy after  radiation and HIFU \/ <strong><em>Volkan  Tu\u011fcu<\/em><\/strong><br>\r\n      <strong>Case 4: <\/strong>Tips and tricks of lymphadenectomy  during radical prostatectomy \/ <strong><em>Osman Raif Karabacak<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <\/table>\r\n    <\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-459684942\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-459684942\" data-tab-index=\"2\" style=\"--n-tabs-title-order: 2;\" class=\"elementor-element elementor-element-18c0021 e-con-full e-flex e-con e-child\" data-id=\"18c0021\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5b69dca elementor-widget elementor-widget-html\" data-id=\"5b69dca\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div style=\"overflow: auto\">\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" class=\"program\">\n  <col width=\"15%\">\n  <col width=\"85%\">\n\n  <tr>\n    <th colspan=\"2\"><strong>17 May 2025 - Saturday <\/strong><\/th>\n  <\/tr>\n  <tr class=\"halla\">\n    <td>&nbsp;<\/td>\n    <td>HALL A<\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>08.00  - 09.15<\/strong><\/td>\n    <td><strong>Locale  advanced disease and recurrence disease in Prostate Cancer<\/strong><br>\n      Moderators:  <strong><em>Yusuf \u00d6zlem \u0130lbey, Alpaslan \u00d6zg\u00fcn, Hasan Bak\u0131rta\u015f<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.00  - 08.10<\/td>\n    <td>Evolving  Landscape of Advanced Prostate Cancer: Guidelines and Case-Based Discussion \/ <strong><em>Necip  Pirin\u00e7\u00e7i<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.10  - 08.20<\/td>\n    <td>The role of neoadjuvant treatment in locally advanced disease \/ <strong><em>Naz\u0131m  Demircan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.20  - 08.30<\/td>\n    <td>Is  all PSA persistence equal? - Optimal treatment of PSA persistence after radical  prostatectomy \/\u00a0<strong><em>Rahim Horuz<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.30  - 09.00<\/td>\n    <td><strong>Current  approach to management of high-risk biochemical recurrence after radical  prostatectomy <\/strong><br>\n      Moderator: <strong><em>Derya  Balbay<\/em><\/strong><br>\n      Panelist:  <strong><em>Ey\u00fcp Veli K\u00fc\u00e7\u00fck, Serdar  Karada\u011f, Turgay Turan, Nil\u00fcfer Duranku\u015f<\/em><\/strong><br>\n      - Early salvage RT w\/o ADT<br>\n      - Systemic treatment alone<\/td>\n  <\/tr>\n  <tr>\n    <td>09.00  - 09.15<\/td>\n    <td>Radioligand  Therapies for Advanced Prostate Cancer \/ <strong><em>Levent Kabasakal <\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"break\">\n    <td>09.15  - 09.30<\/td>\n    <td><strong>Coffee Break<\/strong><\/td>\n  <\/tr>\n  <tr class=\"opening\">\n    <td><strong>09.30  - 10.20<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Opening  Ceremony<\/strong><br>\n      <strong>Congress Chairman:<em> Volkan Tu\u011fcu<\/em><\/strong><br>\n      <strong>Turkish Urology Association Chairman: <em>Irfan Orhan<\/em><\/strong><br>\n      <strong>Honorary President of Turkish Urology Association: <em>Ate\u015f  Kad\u0131o\u011flu<\/em><\/strong><br>\n      <strong>Eurasian Uro-oncological Association Chairman: <em>Ali \u0130hsan Ta\u015f\u00e7\u0131<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"uydu-alt\">\n    <td><strong>10.20  - 10.50<\/strong><\/td>\n    <td><strong> <img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/R-Logo2023-CMYK.jpg\" alt=\"\" width=\"199\"  height=\"35\" align=\"right\"\/>&nbsp;Satellite  Symposium<\/strong><br>\n     <strong>Mechanism of Mixed-Acting Agents in Patients with Overactive Bladder and Propiverine Dosing Options<\/strong><br>\n     Moderator: <em><strong>Rahmi Onur<\/strong><\/em><br>\n     Panelists: <em><strong>Mehmet G\u00f6khan \u00c7ulha<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>10.50  - 12.10<\/strong><\/td>\n    <td><strong>Advanced  disease in Prostate Cancer<\/strong><br>\n      Moderators:  <strong>\u00a0<em>\u00d6ner Odaba\u015f, Sad\u0131k G\u00f6r\u00fcr, Hasan R\u0131za Ayd\u0131n<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>10.50  - 11.05<\/td>\n    <td>Radical  prostatectomy should not be forgotten in oligometastatic prostate cancer \/ <strong><em>\u0130lker Se\u00e7kiner<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>11.05  - 11.20<\/td>\n    <td>Double  vs triple therapy in de novo mHSPCa \/ <em><strong>\u00c7a\u011fatay Arslan<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>11.20  - 11.40<\/td>\n    <td>Shaping  treatment according to genomic profile mHSPCa <strong>\/ <em>Deniz Tural<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>11.40  - 12.10<\/td>\n    <td><strong>Panel: What  should be the decision-making algorithm in mCRPC?<\/strong><br>\n      Moderator: <strong><em>\u00c7a\u011fatay  Arslan<\/em><\/strong><br>\n      Panelists: <strong><em>Erdem Ko\u00e7<\/em><\/strong><em><strong>,<\/strong> <strong>Deniz  Tural<\/strong>, <strong>Nil\u00fcfer Duranku\u015f,<\/strong> <strong>Levent Kabasakal<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <tr class=\"break\">\n    <td><strong>12.10  - 13.00<\/strong><\/td>\n    <td><strong>Lunch Break<\/strong><\/td>\n  <\/tr>\n\n  <tr class=\"session\">\n    <td><strong>13.00  - 14.15<\/strong><\/td>\n    <td><strong>Bladder Cancer Session \u2013 Diagnosis of  bladder cancer and low-risk NMIBC<\/strong><br>\n      Moderators: <strong> <em>Sabahattin Ayd\u0131n, \u00d6mer Sar\u0131lar, \u0130lhan Ge\u00e7it <\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.00  - 13.15<\/td>\n    <td>VI-RADS:  MRI Protocols, Lesion Characterization, and Pitfalls \/ <strong><em>Ayt\u00fcl Hande Yard\u0131mc\u0131<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.15  - 13.30<\/td>\n    <td>Deintensification  of Treatment for Low-grade Bladder Tumors \/ <strong><em>Bekir Aras<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.30  - 13.45<\/td>\n    <td>Is  there a way to skip cystoscopy during follow-up of low and intermediate NMIBC \/ <strong><em>Fuat K\u0131z\u0131lay<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.45 - 14.00<\/td>\n    <td>Treatment strategies for low-risk NMIBC (Fulguration as day care protocol) \/ <em><strong>Emre \u015eam <\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td>14.00  - 14.15<\/td>\n    <td>Treatment  strategies for low-risk NMIBC (Chemoablation in mutated tumors) \/ <em><strong>Ural Oguz<\/strong><\/em><\/td>\n  <\/tr>\n \n  <tr class=\"uydu-alt\">\n    <td><strong>14.15  - 14.45<\/strong><\/td>\n    <td><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/AstraZeneca.jpg\" alt=\"\" width=\"166\"  height=\"55\" align=\"right\"\/>Satellite  Symposium<\/strong><strong><br>\n      The Evolution of Prostate Cancer Treatment from  Zoladex to Lynparza<\/strong><br>\n      Panelists:  <strong><em>Mahmut G\u00fcm\u00fc\u015f, Nurettin  Cem S\u00f6nmez<\/em><\/strong><\/td>\n  <\/tr>\n \n  <tr class=\"break\">\n    <td><strong>14.45  - 15.00<\/strong><\/td>\n    <td><strong>Coffee Break<\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>15.00  - 15.40<\/strong><\/td>\n    <td><strong>Bladder  Cancer Session \u2013 High risk NMIBC<\/strong><br>\n      Moderators:<strong> <em>Hasan Sa\u011flam, Zafer G\u00f6khan G\u00fcrb\u00fcz, Ali \u00c7ift<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.00  - 15.20<\/td>\n    <td>Patient  with high-risk NMIBC: Is BCG still the best option in 2025?<br>\n      Yes, BCG is still  king \/ <strong><em>Berat Cem \u00d6zg\u00fcr<\/em><\/strong><br>\n      No, time to dethrone BCG \/ <strong><em>Levent \u00d6zdal<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.20  - 15.30<\/td>\n    <td>Management of intravesical therapy  complications \/ <strong><em>\u00d6zg\u00fcr Kazan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.30  - 15.40<\/td>\n    <td>Recurrence  after BCG in high-risk NMIBC: something else than RC? \/ <strong> <em>Sacit Nuri G\u00f6rgel<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"uydu-alt\">\n    <td><strong>15.40  - 16.10<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/Mededge.jpg\" alt=\"\" width=\"176\"  height=\"55\" align=\"right\"\/>Satellite  Symposium <br>\n    <\/strong><strong>Robotic  HIFU<\/strong><br>\n      Panelists:  <strong><em>Giovanni Lughezzani <i class=\"fas fa-wifi\"><\/i>, Volkan Tu\u011fcu<\/em><\/strong>      <\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>16.10  - 16.40<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Upper  Tract Urothelial Cancer<\/strong><br>\n      Moderators:<strong> <em>Fikret Halis, Mustafa G\u00fcne\u015f, Cumhur Ye\u015fildal<\/em><\/strong><\/td>\n  <\/tr>\n\n  <tr >\n    <td>16.10 - 16.20<\/td>\n    <td>Low- -risk upper tract urothelial cancer: how safe is to  preserve nephrons? \/ <em><strong>Angelo<\/strong> <strong>Territo <\/strong><\/em><\/td>\n  <\/tr>\n  <tr >\n    <td>16.20  - 16.40<\/td>\n    <td><strong>Case  presentatiton (Patient with high-grade upper tract disease: Neoadjuvant or  adjuvant systemic therapy?)<\/strong><br>\n      Moderator<strong>:  Alper \u00d6t\u00fcn\u00e7temur (Case  Presenter)<\/strong><br>\n      Panelists:  (2 MO)<br>\n      Adjuvant therapy \/ <strong><em>Polat<\/em><\/strong> <em><strong>Olgun<\/strong><\/em> <br>\n      Neoadjuvant therapy better<strong> \/\u00a0<em>Mustafa Atc\u0131<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\" >\n    <td><strong>16.40  - 17.25<\/strong><\/td>\n    <td><strong>Semi-live  Section (Bladder Cancer)<\/strong><br>\n      Moderators:<strong> <em>\u00d6mer Levent Tuncay, H\u00fcseyin Ko\u00e7an<\/em><\/strong><\/td>\n  <\/tr>\n  <tr >\n    <td>&nbsp;<\/td>\n    <td><strong>Case 1: <\/strong>\u00a0Partial cystectomy \u2013 <strong><em>Ya\u015far \u00d6zg\u00f6k<\/em><\/strong><br>\n      <strong>Case 2: <\/strong>Orthotopic Neobladder Reconstruction  - <strong><em>Halil Bozkurt<\/em><\/strong> <br>\n      <strong>Case 3: <\/strong>Cystectomy \u0130n Women<strong> \u2013 <em>Ali Fuat Atmaca<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td colspan=\"2\" class=\"hallb\">HALL B<\/td>\n  <\/tr>\n  <tr class=\"kurs2\">\n    <td><strong>07.30  - 08.45<\/strong><\/td>\n    <td><strong>Laser Enucleation of the Prostate  Masterclass Course <\/strong><br>\n      Moderators: <strong><em>Bahad\u0131r Topuz,<\/em><\/strong><em><strong> Resul Sobay, Erol U\u00e7aner<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>07.30  - 07.45<\/td>\n    <td>Equipment  of prostate laser surgery and optimal patient selection \/ <strong><em>Taner Karg\u0131<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>07.45  - 08.00<\/td>\n    <td>En-bloc  technique \/ <strong><em>Erg\u00fcn Alma<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.00  - 08.15<\/td>\n    <td>Trilober technique \/ <strong><em>Murat Arslan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.15  - 08.30<\/td>\n    <td>Complications  \/ <strong><em>Utku Can<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.30  - 08-45 <\/td>\n    <td>Bipolar Technique<strong> \/ <em>Taylan Oksay<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"oral\">\n    <td><strong>10.30 -  12.15<\/strong><\/td>\n    <td><strong>Oral Presentation 1<\/strong><br>\n      Moderators:<strong> <em>H\u00fcseyin Ayta\u00e7 Ate\u015f, Mithat Ek\u015fi<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"oral-alt\">\n    <td>&nbsp;<\/td>\n    <td><table cellspacing=\"0\" cellpadding=\"0\" style=\"font-size: 10pt;\">\n    \n      <tr>\n        <td width=\"96\">SS-01<\/td>\n        <td width=\"823\">Clinical    outcomes of the patients referred due to incidental uptake in the prostate    gland on FDG PET-CT<\/td>\n        <td width=\"179\">Sebnem    Hekimoglu<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-02<\/td>\n        <td>Preoperatif d\u00f6nemde    \u00e7ekilen PSMA PET\/BT radyomik de\u011ferleri paralelinde yapay zeka yard\u0131m\u0131yla    cerrahi sonras\u0131 biyokimyasal n\u00fcks \u00f6ng\u00f6r\u00fclebilir mi?<\/td>\n        <td>O\u011fuzhan \u00d6zt\u00fcrk<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-03<\/td>\n        <td>The influence of    physical activity on quality of life after radical prostatectomy in    sarcopenic patients identified by PSMA PET\/CT<\/td>\n        <td>As\u0131f Y\u0131ld\u0131r\u0131m<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-04<\/td>\n        <td>Prostat Transizyonel    Zonda PIRADS 3 Lezyonu Olan Hastalarda Dutasteridin Sonraki Multiparametrik    Prostat MR Sekanslar\u0131na ve PIRADS Skoruna Etkisi<\/td>\n        <td>Akif Erbin<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-05<\/td>\n        <td>Biyopsi Naiv    Hastalarda Multiparametrik Manyetik Rezonans G\u00f6r\u00fcnt\u00fcleme-Transrektal Ultrason    F\u00fczyon (MRUS-TB) ve Kognitif F\u00fczyon (COG-TB) Hedefli Prostat Biyopsilerinde    \u0130ndeks Lezyon Boyutunun Prostat Kanseri Saptanmas\u0131nda Etkisinin    Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<\/td>\n        <td>Kamuran Tav\u015fan<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-06<\/td>\n        <td>NPRL2 Gene Expression    as a Predictive Marker for Biochemical Recurrence After Robot-Assisted    Radical Prostatectomy: A Retrospective Cohort Study<\/td>\n        <td>Kaz\u0131m Ceviz<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-07<\/td>\n        <td>\u00dc\u00e7 Boyutlu    Laparoskopik Radikal Prostatektomi: 500 olgunun analizi<\/td>\n        <td>Necip Pirin\u00e7\u00e7i<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-08<\/td>\n        <td>Freehand    Transperineal Prostat Biyopsisi: Onkolojik ve Fonksiyonel Sonu\u00e7lar\u0131m\u0131z<\/td>\n        <td>Ahmet Tu\u011frul T\u00fcrkay<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-09<\/td>\n        <td>Transrektal    ultrasonografi rehberli\u011finde prostat biyopsisinden \u00f6nce topikal diltiazem    kullan\u0131m\u0131n\u0131n hastan\u0131n a\u011fr\u0131, i\u015flem memnuniyeti ve i\u015flemi tekrarlama iste\u011fi    \u00fczerine etkisi: randomize kontroll\u00fc bir \u00e7al\u0131\u015fma<\/td>\n        <td>Hasan Salih K\u00f6se<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-10<\/td>\n        <td>PIRADS 5 Lezyonlar\u0131n    Patolojik Sonu\u00e7lar\u0131<\/td>\n        <td>H\u00fcseyin Batur<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-11<\/td>\n        <td>Prostat Kanserinde    Aktif \u0130zlem: \u0130ki Y\u0131l Sonra Ne G\u00f6r\u00fcyoruz?<\/td>\n        <td>Mustafa I\u015f\u0131kdo\u011fan<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-12<\/td>\n        <td>Robot Yard\u0131ml\u0131    Radikal Prostatektomi Uygulanan Hastalarda Lenf Nodu Pozitifli\u011finin Tomografi    ve PSMA G\u00f6r\u00fcnt\u00fcleme ile \u00d6n G\u00f6r\u00fclme Ba\u015far\u0131s\u0131n\u0131n Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<\/td>\n        <td>F\u0131rat \u00c7a\u011flar Budak<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-13<\/td>\n        <td>\u0130nsan Papillomavir\u00fcs\u00fc    (HPV) ile Prostat Kanseri Aras\u0131ndaki Olas\u0131 \u0130li\u015fkinin De\u011ferlendirilmesi<\/td>\n        <td>Sedat Zengin<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-14<\/td>\n        <td>Y\u00fcksek Riskli MR    Bulgular\u0131 Olan Hastalarda Gereksiz Prostat Biyopsisini \u00d6nlemeye Y\u00f6nelik    Nomogram\u0131n Eksternal Validasyonu<\/td>\n        <td>Arda Meric<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-15<\/td>\n        <td>B\u00fcy\u00fck Dil Modelleri    ile klinik performans k\u0131yaslamas\u0131: \u00dcrolojik vaka senaryolar\u0131nda ChatGPT,    NotebookLM ve uzman yan\u0131tlar\u0131n\u0131n de\u011ferlendirilmesi<\/td>\n        <td>Hasan Cem Yakut<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-16<\/td>\n        <td>Patient    characteristics and trends in active surveillance for prostate cancer: a    retrospective cohort study<\/td>\n        <td>Hikmet Enes Canpolat<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-17<\/td>\n        <td>MR Pozitif Hastalarda    Freehand Transperineal ve Transrektal Prostat Kognitif F\u00fczyon Biyopsi    Sonu\u00e7lar\u0131n\u0131n Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<\/td>\n        <td>Ahmet Ko\u015fargelir<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-18<\/td>\n        <td>Metastatik Prostat    Kanserinde Nadir G\u00f6r\u00fclen Kateter Enfeksiyonu Mor \u0130drar Torbas\u0131 Sendromu<\/td>\n        <td>Cemil Kutsal<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-19<\/td>\n        <td>Metabolic Syndrome is    Associated with the Presence of Prostate Cancer Detected on Biopsy, but Not    with Gleason Score or Cancer-Positive Core Number: A Prospective Controlled    Study<\/td>\n        <td>Salih Y\u0131ld\u0131r\u0131m<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-20<\/td>\n        <td>Radikal Prostatektomi    Sonras\u0131 Gleason Upgrade&rsquo;e Klinik Fakt\u00f6rlerin ve Patolojik De\u011ferlendirmeyi    Yapan Patolo\u011fun Etkisi<\/td>\n        <td>Berkay Eren<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-21<\/td>\n        <td>Evaluation of    Homeobox Protein B13 (HOXB13) Gene G84E Mutation in Patients with Prostate    Cancer<\/td>\n        <td>Melih B\u0131y\u0131ko\u011flu<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-22<\/td>\n        <td>Definitif    Hipofraksiyone Pelvik Nodal Radyoterapi Uygulanan Prostat Kanseri Tan\u0131l\u0131    Hastalarda Dozimetrik Verilerle Akut Toksisite Sonu\u00e7lar\u0131<\/td>\n        <td>N\u00fclifer K\u0131l\u0131\u00e7 Duranku\u015f<\/td>\n      <\/tr>\n    <\/table><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>13:15  - 14.30<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Asian  Turkic Republics Session <\/strong><br>\n      Moderators: <strong><em>Rauf Na<\/em><\/strong><em><strong>\u011f\u0131yev,  Fuad Guliyev, Volkan Tu\u011fcu<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>13.15 - 13. 30<\/td>\n    <td>Kidney transplantation in  uro-oncological patients  \/ <strong><em>Re\u015fad \u015eolan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>13.30 - 13.45 <\/td>\n    <td>Benign and precancerous  lesions of the bladder \/ <strong><em>Rashad Mammadov<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>13.45 - 14. 00<\/td>\n    <td>Robot-assisted radical cystectomy with intracorporeal ileal neobladder (Bordeaux technique) \/ <strong><em>C\u00fcneyt \u00d6zden<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>14.00 - 14.15<\/td>\n    <td>New Robotic Systems \/ <strong><em>Halil Lutfi Canat<\/em><\/strong><em> <\/em><\/td>\n    <\/tr>\n  <tr>\n    <td nowrap>14.15 - 14.30<\/td>\n    <td>The role of minimally  invasive surgery in urooncology: Our experience  \/ <strong><em>Xusan Umurzakov<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"break\">\n    <td nowrap><strong>14.30 - 15.15 <\/strong><\/td>\n    <td><strong>Break<\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td align=\"left\" nowrap><strong>15.15 - 17.00<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Balkan  Countries Session <\/strong><br>\n      Moderators: <strong><em>Taner Yusuf, Gezim Galiqi, Ali  \u0130hsan Ta\u015f\u00e7\u0131<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>15.15 - 15.30<\/td>\n    <td>The rs2304277 polymorphism in OGG1 gene in  bladder&nbsp;cancer <strong> \/ <em>Bujar Frangu<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>15.30 - 15.45<\/td>\n    <td>Treatment of Kindey Tumors in Albania \/ <em><strong>Aurel  Janko<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>15.45 - 16. 00<\/td>\n    <td>Tips and Tricks in Robotic Cystectomy \/ <em><strong>Volkan Tu\u011fcu<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>16.00 - 16.15<\/td>\n    <td>Testosteron paradigm in Prostate Cancer \/ <em><strong>Senad  Bayramovic<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td nowrap>16.15 - 16.30<\/td>\n    <td>Laparoscopic and robotic  surgery for kidney tumors \/ <em><strong>Y\u0131lmaz  Arslan<\/strong><\/em><\/td>\n    <\/tr>\n  <tr>\n    <td nowrap>16.30 - 16.45<\/td>\n    <td>Clinical Approach to urinary bladder tumors at  the urology clinic in Skopje \/ <em><strong>Skender Saidi<\/strong><\/em><\/td>\n    <\/tr>\n  <tr>\n    <td nowrap>16.45 - 17.00 <\/td>\n    <td>Relationship of the rs2279744 polymorphysm in the MDM2 gen with the invassivnes of blader carcinoma \/ <em><strong>Ardian Prenaj<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-459684943\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-459684943\" data-tab-index=\"3\" style=\"--n-tabs-title-order: 3;\" class=\"elementor-element elementor-element-793d9ab e-con-full e-flex e-con e-child\" data-id=\"793d9ab\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-46ee728 elementor-widget elementor-widget-html\" data-id=\"46ee728\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div style=\"overflow: auto\">\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" class=\"program\">\n  <col width=\"15%\">\n  <col width=\"85%\">\n    \n  <tr>\n    <th colspan=\"2\"><strong>18 May 2025 - Sunday<\/strong><\/th>\n  <\/tr>\n  <tr class=\"halla\">\n    <td>&nbsp;<\/td>\n    <td>HALL A<\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>08.00  - 09.20<\/strong><\/td>\n    <td><strong>Bladder  Cancer Session \u2013 MIBC and Advance Disease<\/strong> <br>\n      Moderators:<strong> <em>Enver \u00d6zdemir, Aykut Colakerol<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.00  - 08.10<\/td>\n    <td>Bladder  preservation protocols in MIBC: What&rsquo;s new? <strong>\/ <em>Sel\u00e7uk Erdem<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.10  - 08.20<\/td>\n    <td>Limits  of lymphadenectomy in muscle-invasive bladder cancer - <strong><em>Mehmet Giray S\u00f6nmez<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.20  - 08.35<\/td>\n    <td>Systemic  therapy for advanced bladder cancer \/ <strong><em>Emir \u00c7elik<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.35  - 08.50<\/td>\n    <td>Health  related quality of life after curative treatment for muscle invasive bladder  cancer \/ <strong><em>Rahmi Arslan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.50  - 09.20<\/td>\n    <td><strong>Can we  avoid radiation in the new consolidation treatment landscape with optimal  systemic therapy? <\/strong><br>\n      Moderators:<strong> <em>\u00d6zkan Polat, \u0130brahim Karabulut<\/em><\/strong><br>\n      Case Presenter: <strong><em>As\u0131f Y\u0131ld\u0131r\u0131m<\/em><\/strong><br>\n      - Yes: Avoid  radiation, systemic therapy is enough \/ <strong><em>Seval Ay<\/em><\/strong><br>\n      - No: Radiation mandatory with  systemic therapy \/ <strong><em>Nil\u00fcfer Duranku\u015f<\/em><\/strong><br>\n      - No: Surgery mandatory with systemic  therapy \/ <strong><em>Oktay Ak\u00e7a <\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"uydu-alt\">\n    <td><strong>09.20  \u2013 09.50<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/R-Logo2023-CMYK.jpg\" alt=\"\" width=\"199\"  height=\"35\" align=\"right\"\/>Satellite  Symposium<\/strong><br>\n      <strong>ELIGARD\u00ae IN PROSTATE CANCER TREATMENT: CLINICAL CASE REPORTS AND SUCCESS STORIES<\/strong><br>\n      Moderator: <em><strong>B\u00fclent Akduman<\/strong><\/em><br>\n      Panelist: <em><strong>Alper Bitkin<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  \n  <tr class=\"break\">\n    <td>09.50  - 10.00<\/td>\n    <td><strong>Coffee Break<\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>10.00  - 11.15<\/strong><\/td>\n    <td><strong>Bladder  Cancer Session \u2013 Metastatic Disease<\/strong> <br>\n      Moderators:  <strong><em>Turgut Yapano\u011flu, Mehmet Kaynar, \u00d6mer Y\u0131lmaz<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>10.00  - 10.15<\/td>\n    <td>Local  treatments of oligometastatic bladder cancer, when and how? \/ <strong><em>Muammer Bozkurt<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>10.15  - 10.30<\/td>\n    <td>Current  approaches in the beyond first line treatment of metastatic bladder cancer \/ <strong><em>Deniz Tural<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>10.30  - 10.45<\/td>\n    <td>Management of the postoperative urological complication in patients with MIBC \/ <strong><em>\u00d6mer<\/em><\/strong> <em><strong>Levent Tuncay<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td>10.45 -  11.15<\/td>\n    <td><strong>Anesthesia  and Cardiology Consultations in Urology<\/strong><br>\n      Patients using blood thinners: Bleeding or obstruction? \/ <strong><em>Kamil Mehmet Tugrul<\/em><\/strong><br>\n       Preoperative cardiac evaluation in urological  patients  \/ <strong><em>Hasan Burak \u0130\u015fleyen<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"panel\">\n    <td><strong>11.15  - 12.00<\/strong><\/td>\n    <td><strong>Legal and  Ethical Dilemmas in Urooncology <\/strong><br>\n      Moderator:  <strong><em>Ali \u0130hsan Ta\u015f\u00e7\u0131<\/em><\/strong><br>\n      Panelists:<strong> <em>\u0130hsan Karaman, Ey\u00fcp G\u00fcm\u00fc\u015f, Mahmut G\u00fcm\u00fc\u015f, Selami Albayrak<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"break\">\n    <td><strong>12.00  - 12.45<\/strong><\/td>\n    <td><strong>Lunch Break<\/strong><\/td>\n  <\/tr>\n \n  <tr class=\"session\">\n    <td><strong>12.45  - 14.15<\/strong><\/td>\n    <td><strong><img decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/simultane.png\" alt=\"\" width=\"30\"  height=\"30\" align=\"right\"\/>Renal  Cancer Session - 1<\/strong><br>\n      Moderators:<strong> <em>Sedat Soyupek, Fatih Oguz<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>12.45  - 13.00<\/td>\n    <td>Are  there any changes in the management of complex renal cysts in 2025? \/ <em><strong>Ahmet Kele\u015f<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.00  - 13.15<\/td>\n    <td>Genomic  profiling and novel therapeutic target of renal cell carcinoma- Who, When, and  How? \/ <strong><em>Seher Y\u0131ld\u0131z Tacal<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.15  - 13.30<\/td>\n    <td>Is  there a role for multiparametric MRI in kidney tumors? Does it provide  additional advantages? \/ <strong><em>Nesrin G\u00fcnd\u00fcz<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>13.30  - 14.00<\/td>\n    <td><strong>3 cm  SRM-risk stratification for SRM<\/strong><br>\n      Moderators: <strong>\u00a0<em>Muhammet G\u00fczelsoy<\/em><\/strong><em><strong>, Fatih Uru\u00e7<\/strong> <\/em><br>\n      - PN \/ <strong><em>Yi\u011fit Ak\u0131n<\/em><\/strong><br>\n      - Focal  Ablation \/ <strong><em>Pilar Laguna<\/em> <i class=\"fas fa-wifi\"><\/i><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>14.00  - 14.15<\/td>\n    <td>New  developments in renal cell carcinoma treatment \/ <em><strong>Didem Kara\u00e7etin<\/strong> <\/em><br>\n      Radiotherapy for  renal cell carcinoma<\/td>\n  <\/tr>\n \n  <tr class=\"uydu-alt\">\n    <td>14.15  - 14.45<\/td>\n    <td><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/alchemlife-logo.jpg\" alt=\"\" width=\"180\"  height=\"45\" align=\"right\"\/>Satellite  Symposium <\/strong><br>\n      <strong>PROSTAQUIL: Improvement in BPH and Chronic Prostatitis Symptoms  Without Side Effects<\/strong><br>\n      Moderators:<strong> <em>Volkan Tu\u011fcu, \u00d6mer  Sar\u0131lar<\/em><\/strong><br>\n      Panelist:<strong> <em>Faruk \u00d6zg\u00f6r<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"break\">\n    <td>14.45  - 15.00<\/td>\n    <td><strong>Break<\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>15.00  - 15.30<\/strong><\/td>\n    <td><strong>Renal  Cancer Session - 2<\/strong><br>\n      Moderators:<strong> <em>Erdal Apayd\u0131n, Soner G\u00fcney, Cemil Kutsal<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.00  - 15.10<\/td>\n    <td>Cytoreductive  and consolidation radical nephrectomy timing and candidates \/ <strong><em>Sel\u00e7uk Erdem <\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.10  - 15.20<\/td>\n    <td>Best  approach for a renal tumor with caval thrombus (Open \/ Robotic) \/ <strong><em>Faruk \u00d6zcan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.20  - 15.30<\/td>\n    <td>Case-Based  Session: Failure of Immunotherapy in Renal Cell Cancer: What&rsquo;s Next? \/ <strong><em>\u0130lkay  G\u00fclt\u00fcrk<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"uydu-alt\">\n    <td><strong>15.30  - 16.10<\/strong><\/td>\n    <td><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/eua25.org\/wp-content\/uploads\/2025\/05\/Abdi_Ibrahim_Logo_Renkli.jpg\" alt=\"\" width=\"207\"  height=\"40\" align=\"right\"\/>Satellite  Symposium <br>\nErectile Disfunction Treatment After Radical Prostatectomy<\/strong><br>\n      Panelists:<strong> <em>Ate\u015f Kad\u0131o\u011flu, Volkan Tugcu,  As\u0131f Y\u0131ld\u0131r\u0131m<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>16.10  - 16.30<\/strong><\/td>\n    <td><strong>Case  presentatiton (Keeping up with the pace in renal cell cancer)<\/strong><br>\n      Moderators: <strong><em>Zeki Bayraktar, Burak Arslan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>&nbsp;<\/td>\n    <td>Presenter: <strong><em>Sinan Celen<\/em><\/strong><br>\n      Panelists: <br>\n      <strong>High risk RCC, adjuvant  treatment <\/strong><br>\n      - Surveillance is beneficial \/ <strong><em>As\u0131f Y\u0131ld\u0131r\u0131m<\/em><\/strong><br>\n      - Adjuvant IO is beneficial \/\u00a0<em><strong>\u00d6zcan Y\u0131ld\u0131z<\/strong> \u00a0<\/em><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>16.30  - 16.50<\/strong><\/td>\n    <td><strong>Case  presentatiton (Management of recurrence after curative surgery: New standard of  care?)<\/strong><br>\n      Moderators:<strong> <em>Ercan Yeni, Fatih Akka\u015f<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>&nbsp;<\/td>\n    <td>Presenter:<strong> <em>Mehmet \u00c7a\u011fatay \u00c7i\u00e7ek<\/em><\/strong><br>\nPanelists: <em><strong>As\u0131f Y\u0131ld\u0131r\u0131m,<\/strong> <strong>\u00d6zcan  Y\u0131ld\u0131z, Eseng\u00fcl Ko\u00e7ak <i class=\"fas fa-wifi\"><\/i><\/strong><\/em><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>16.50  - 17.40<\/strong><\/td>\n    <td><strong>Semi-live  Section (Kidney Cancer)<\/strong><br>\nModerators:<em> <strong>Ahmet Yaser M\u00fcsl\u00fcmano\u011flu,  Ediz Vuru\u015fkan, Erdem K\u0131sa<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td>&nbsp;<\/td>\n    <td>- Case 1:  Multipl tumor \/<em><strong>\u00a0Mutlu Ate\u015f<\/strong><\/em><br>\n      - Case 2: Vena cava trombosis<strong> \/ <\/strong><em><strong>Volkan  Tu\u011fcu<\/strong><strong> <\/strong><\/em><br>\n      - Case 3: Total endophitic \/ <em><strong> Yusuf Kasap<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td class=\"hallb\">&nbsp;<\/td>\n    <td class=\"hallb\">HALL B<\/td>\n  <\/tr>\n  <tr class=\"kurs2\">\n    <td><strong>07.30  - 09.00<\/strong><\/td>\n    <td><strong>Penile Rehabilitation after Uro-oncology  Surgeries: Masterclass Course<\/strong><br>\n      Moderators: <strong><em>Ate\u015f Kad\u0131o\u011flu, Sefa Resim, Irfan Orhan<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>07.30  - 07.45<\/td>\n    <td>Which  patient should receive phosphodiesterase inhibitors, and when? \/ <strong><em>Ufuk \u00c7aglar<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>07.45  - 08.00<\/td>\n    <td>Stem cell therapy for erectile  dysfunction\u00a0\/<strong> <em>Murat Dursun<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.00  - 08.15<\/td>\n    <td>Li-ESWT therapy for erectile dysfunction \/<em> <strong>\u015eahin K\u0131l\u0131\u00e7<\/strong><\/em><\/td>\n  <\/tr>\n  <tr>\n    <td>08.15  - 08.30<\/td>\n    <td>Penile  prothesis implantation (penoscrotal \/ infrapubic) \/ <strong><em>Orhan Koca<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>08.30  - 09.00<\/td>\n    <td>Is  penis enlargement necessary after radical prostatectomy? \/ <strong><em>Ate\u015f Kad\u0131o\u011flu<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"oral\">\n    <td><strong>10.00  - 12.00<\/strong><\/td>\n    <td><strong>Video Presentation 1<\/strong><br>\n      Moderators: <strong><em>Ufuk \u00d6zt\u00fcrk, Bilal Hamarat, Mustafa Erko\u00e7<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"oral-alt\">\n    <td>&nbsp;<\/td>\n    <td><table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" style=\"font-size: 10pt;\">\n     \n      <tr>\n        <td nowrap=\"nowrap\">VS-01<\/td>\n        <td>Retroperitoneal    laparoskopik radikal prostatektomi: 20 y\u0131ll\u0131k bilateral inguinal herniyle    m\u00fccadele<\/td>\n        <td>Erdem Orman<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-02<\/td>\n        <td>Renal H\u00fccreli    Karsinomun Kontralateral Adrenal Metastaz\u0131: Laparoskopik Adrenalektomi<\/td>\n        <td>\u015eaban Kadir K\u00f6leli<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-03<\/td>\n        <td>Unilateral Senkron    Lezyonlara Laparoskopik {\u0130skemisiz} Parsiyel Nefrektomi<\/td>\n        <td>Ali Ertan Okatan<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-04<\/td>\n        <td>Robot Yard\u0131ml\u0131    Retzius Koruyucu Radikal Prostatektomi<\/td>\n        <td>Murat Beyatl\u0131<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-05<\/td>\n        <td>Atipik Yerle\u015fimli    RCC: Retroperitoneal Kitleye Laparoskopik Eksizyon<\/td>\n        <td>Muhammed Emin Polat<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-06<\/td>\n        <td>Posterior    Rhabdosfinkter Rekonstr\u00fcksiyonu Uygulanan Retroperitonoskopik Radikal    Prostatektomi Olgusu<\/td>\n        <td>Salim Tozan<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-07<\/td>\n        <td>Abdominal Aorta    Greftli Hastada Laparoskopik Sol Radikal Nefrektomi<\/td>\n        <td>Hasan Oru\u00e7 Ero\u011flu<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-08<\/td>\n        <td>Morbit obez hastada 8    cm lik adrenal kitleye 3 boyutlu laparaskopik cerrahi eksizyon<\/td>\n        <td>Ahmet Faruk Akat<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-09<\/td>\n        <td>Laparoskopik    Retroperitoneal Kitle Eksizyonu<\/td>\n        <td>Volkan Enes \u00c7elik<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-10<\/td>\n        <td>Laparoskopik Y\u00f6ntemle    Retroperitoneal Kitle Eksizyonu: Ekstraadrenal Paraganglioma Olgusu<\/td>\n        <td>Alp Bardakc\u0131<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-11<\/td>\n        <td>Laparoskopik Parsiyel    Nefrektomi Uygulanan At Nal\u0131 B\u00f6brekli Renal T\u00fcm\u00f6r Vakas\u0131: Nadir Anatomik    Varyasyonlara Cerrahi Yakla\u015f\u0131m<\/td>\n        <td>Utku Can<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-12<\/td>\n        <td>Laparoskopik Radikal    Prostatektomi Sonu\u00e7lar\u0131m\u0131z: Hemostatik S\u00fct\u00fcr veya Klips Gerekli Mi?<\/td>\n        <td>Tural Miriyev<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-13<\/td>\n        <td>Use of barbed suture    for continuous urethro-vesical anastomosis in open retropubic radical    prostatectomy: A new approach<\/td>\n        <td>Akif Erbin<\/td>\n      <\/tr>\n      <tr>\n        <td>VS-14<\/td>\n        <td>Radikal Prostatektomi    Ameliyat\u0131nda Yeni Bir Modifikasyon: Denonviller Fasyas\u0131na Posteroanterior    Yakla\u015f\u0131m<\/td>\n        <td>Emrecan G\u00f6k\u015fin<\/td>\n      <\/tr>\n    <\/table><\/td>\n  <\/tr>\n  <tr class=\"oral\">\n    <td><strong>12.45  - 14.15<\/strong><\/td>\n    <td><strong>Oral Presentation 2<\/strong><br>\n      Moderators: <strong><em>\u00d6zkan Polat, Mehmet Kaynar, \u0130smail Evren<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"oral-alt\">\n    <td>&nbsp;<\/td>\n    <td><table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" style=\"font-size: 10pt;\">\n   \n      <tr>\n        <td nowrap=\"nowrap\">SS-23<\/td>\n        <td>Mesane    T\u00fcm\u00f6rlerinde DJ Stent Ve \u00dcst \u00dcriner Sistem T\u00fcm\u00f6r\u00fc Riski<\/td>\n        <td>Muhammed Fatih    Kele\u015f<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-24<\/td>\n        <td>Mesane t\u00fcm\u00f6r\u00fcnde    neoadjuvan kemoterapinin final patoloji \u00fczerine etkisi<\/td>\n        <td>Muhammed Fahri Samuk<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-25<\/td>\n        <td>Estimation of    Physiologic Ability and Surgical Stress (E\u2011PASS) Skorlamas\u0131n\u0131n Radikal    Sistektomi Yap\u0131lan Hastalarda Postoperatif Komplikasyonlar\u0131 \u00d6ng\u00f6r\u00fc De\u011feri<\/td>\n        <td>M\u00fccahit Gelmi\u015f<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-26<\/td>\n        <td>Mesane Kanseri ve    Tedaviye Diren\u00e7li Pelvik A\u011fr\u0131 Sendromu Olan Kad\u0131nlarda Genital Organ Koruyucu    Radikal Sistektomi ve Ortotopik Mesane Rekonstr\u00fcksiyonu Operasyonunun,    Onkolojik ve Fonksiyonel Sonu\u00e7lar\u0131<\/td>\n        <td>Cuneyd Sevinc<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-27<\/td>\n        <td>Effects of    Dutasteride with Bacillus Calmette-Gu\u00e9rin Therapy on Recurrence, Progression,    Metastasis, and Survival in Non-Muscle Invasive Bladder Cancer: A    Retrospective Single-Center Study<\/td>\n        <td>Ali Nebio\u011flu<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-28<\/td>\n        <td>Alb\u00fcmin globulin    oran\u0131 kas invaziv mesane kanserinde sistektomi \u00f6ncesi neoadjuvan kemoterapiye    yan\u0131t\u0131 \u00f6ng\u00f6r\u00fcr m\u00fc?<\/td>\n        <td>Ahmet Boylu<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-29<\/td>\n        <td>\u0130leal Ortotopik    Neobladder, \u00dcreterok\u00fctanostomi veya \u0130leal Konduitli Ya\u015fl\u0131 Hastalarda Mesane    Kanseri \u0130\u00e7in Radikal Sistektomi Sonras\u0131 Sa\u011fl\u0131kla \u0130lgili Ya\u015fam Kalitesi:    Do\u011frulanm\u0131\u015f Anketler Kullan\u0131larak Yap\u0131lan Kesitsel \u00c7al\u0131\u015fma<\/td>\n        <td>Bu\u011fra Aksay<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-30<\/td>\n        <td>Mesane t\u00fcm\u00f6r\u00fc    rezeksiyonunda thulium lazer kullan\u0131m\u0131n\u0131n operatif ve onkolojik k\u0131sa d\u00f6nem    sonu\u00e7lar\u0131n\u0131n de\u011ferlendirilmesi<\/td>\n        <td>Can Ulu\u00e7ay<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-31<\/td>\n        <td>Kas \u0130nvaziv Olmayan    Mesane Kanserinde Primer TUR ve Second TUR Aras\u0131ndaki S\u00fcrenin Erken D\u00f6nem    N\u00fcksler \u00dczerine Etkisi: Tek Merkez Deneyimimiz<\/td>\n        <td>Yunus Emre D\u00fc\u015f\u00fcn\u00fc\u015f<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-32<\/td>\n        <td>CALD1, JAK1 ve STAT5    ekspresyonunun mesane kanserinde prognoza etkisi: \u0130mm\u00fcnoterapide yeni hedef    molek\u00fcller olabilir mi?<\/td>\n        <td>\u0130brahim Halil Balo\u011flu<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-33<\/td>\n        <td>Kasa \u0130nvaze Olmayan    Mesane Kanserinde BCG Tedavisi Komplikasyonlar\u0131n\u0131n Predikt\u00f6rleri:    Clavien-Dindo Temelli \u00c7al\u0131\u015fma<\/td>\n        <td>Ilkin Hamid-Zada<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-34<\/td>\n        <td>Kasa invaziv Olmayan    Y\u00fcksek Riskli Mesane T\u00fcm\u00f6rl\u00fc Hastalarda HIVEC Tedavisinin K\u0131sa D\u00f6nem    Sonu\u00e7lar\u0131n\u0131n De\u011ferlendirilmesi<\/td>\n        <td>Yusuf \u00d6zl\u00fclerden<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-35<\/td>\n        <td>Are Simultaneous    Laparoscopic Cystoprostatectomy and Nephroureterectomy Safe? Case    Presentation<\/td>\n        <td>Ahmet U\u00e7ar<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-36<\/td>\n        <td>HIV Negatif 73 Ya\u015f    Erkek Hastada Penil Kaposi Sarkomu: Nadir Bir Olgu Sunumu<\/td>\n        <td>Erhan \u015eengel<\/td>\n      <\/tr>\n      <tr>\n        <td>SS-37<\/td>\n        <td>Hemat\u00fcri ile Ba\u015fvuran    Mesane Kanseri Hastalar\u0131nda Anjioembolizasyon Tecr\u00fcbelerimiz<\/td>\n        <td>Ahmet Eren Sa\u011f\u0131r<\/td>\n      <\/tr>\n      <tr>\n        <td nowrap=\"nowrap\">SS-38<\/td>\n        <td>Radikal    Sistoprostatektomi Esnas\u0131nda Komplet Urakus Eksizyonu Onkolojik A\u00e7\u0131dan    Gerekli mi?<\/td>\n        <td>Bar\u0131\u015f Esen<\/td>\n      <\/tr>\n    <\/table><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>14.30  - 16.00<\/strong><\/td>\n    <td><strong>Incontinence following radical  prostatectomy<\/strong><br>\n      Moderators:<strong> <em>Adem Fazl\u0131oglu, Burhan Co\u015fkun, Asl\u0131 Ba\u015faran<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>14.30  - 14.45<\/td>\n    <td>Definition  of incontinence after radical prostatectomy and methods for assessing  incontinence \/ <strong> <em>Mehmet G\u00f6khan \u00c7ulha<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>14.45  - 15.00<\/td>\n    <td>Pelvic Floor Muscle Training After Radical Prostatectomy: Its Role and Importance \/ <em><strong> Ece \u00d6zkan<\/strong><\/em><strong><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.00 -  15.15<\/td>\n    <td>Medical  Treatmenf of incontinence after radical prostatectomy \/ <strong><em>Hakan \u00c7ak\u0131c\u0131 <\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.15  - 15.30<\/td>\n    <td>Midurethral sling procedures for  incontinence after radical prostatectomy \/ <strong> <em>Rahmi Onur<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>15.30 - 16.00<\/td>\n    <td>Artificial  Urinary Sphincther<strong> \/ <em>Hakan  Akdere<\/em><\/strong><\/td>\n  <\/tr>\n  <tr class=\"session\">\n    <td><strong>16:00  - 17:05<\/strong><\/td>\n    <td><strong>Post-Prostatectomy strictures: Anastomosis strictures, Bladder neck strictures, Urethra strictures<\/strong><br>\n      Moderators:<strong> <em>Selami Albayrak, Murat T\u00fcken, Emre CanPolat<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>16.00  - 16.15 <\/td>\n    <td>Muscle and vessel sparing urethroplasty  \/ <strong><em>Abdurrahim  \u0130mamoglu<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>16.15  - 16.35<\/td>\n    <td>Medical treatment, Endoscopic treatments and Stents <strong> \/ <em>Kubilay Sabuncuo\u011flu<\/em><\/strong><\/td>\n  <\/tr>\n  <tr>\n    <td>16.35  - 17.05<\/td>\n    <td><strong>Surgical  repair<\/strong><br>\n      - Anastomosis strictures, Bladder neck strictures, Urethra strictures  after RT  &nbsp; \/\u00a0<strong><em>Rahim Horuz <\/em><\/strong><br>\n      - Post-Prostatectomy strictures after radical prostate?  \/ <strong>Fatih Yal\u00e7\u0131nkaya<\/strong><\/td>\n  <\/tr>\n  <\/table>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-459684944\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-459684944\" data-tab-index=\"4\" style=\"--n-tabs-title-order: 4;\" class=\"elementor-element elementor-element-d281b10 e-con-full e-flex e-con e-child\" data-id=\"d281b10\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2d06086 elementor-widget elementor-widget-html\" data-id=\"2d06086\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div style=\"overflow: auto\">\r\n<table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" class=\"program\">\r\n  <col width=\"15%\">\r\n  <col width=\"85%\">\r\n    \r\n  <tr>\r\n    <th colspan=\"2\"><strong>19 May 2025 - Monday<\/strong><\/th>\r\n  <\/tr>\r\n  <tr class=\"halla\" >\r\n    <td>&nbsp;<\/td>\r\n    <td class=\"halla\">HALL A<\/td>\r\n  <\/tr>\r\n  <tr class=\"session\">\r\n    <td><strong>08.00  - 09.00<\/strong><\/td>\r\n    <td><strong>Benign Prostatic Hyperplasia <\/strong><br>\r\n      Moderators: <strong><em>Abdullah Demirta\u015f, Murat Zor, G\u00f6khan G\u00f6k\u00e7e<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.00 - 08.10<\/td>\r\n    <td>Combination  therapies for LUTS \/ <strong><em>Emre  Alt\u0131nta\u015f<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.10 - 08.20<\/td>\r\n    <td>Holmium \/ <strong><em>Murat Arslan<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.20 - 08.30<\/td>\r\n    <td>Thulium  or Thulium Fiber? Which energy to which patient? \/ <strong><em>Murat Zor<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.30 - 08.40<\/td>\r\n    <td>REZUM \/ <strong><em>C\u00fcneyt Sevin\u00e7<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.40 -    08.50\u00a0<\/td>\r\n    <td>Laparoscopic  adenomectomy \/ <strong><em>Mehmet \u00c7a\u011fatay  \u00c7i\u00e7ek<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.50  - 09.00<\/td>\r\n    <td>Discussion<\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td><\/td>\r\n    <td><\/td>\r\n  <\/tr>\r\n  <tr class=\"session\">\r\n    <td><strong>09.00    - 10.00 <\/strong><\/td>\r\n    <td><strong>EAU  Session - What&rsquo;s new in the 2025 congress?<\/strong><br>\r\n      Moderator:<strong> <em>Adem Altunkol<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>09.00  - 09.15<\/td>\r\n    <td>Prostate  Cancer <strong>\/ <em>Abdullah Yavuzsan<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>09.15  - 09.30<\/td>\r\n    <td>MIBC \/ <strong>\u00a0<em>K\u00fcr\u015fat K\u00fc\u00e7\u00fcker<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>09.30  - 09.45<\/td>\r\n    <td>Renal  Cell Carcinoma \/<strong> <em>Enis Mert  Yorulmaz<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr class=\"break\">\r\n    <td><strong>09.45  - 10.00<\/strong><\/td>\r\n    <td><strong>Coffee Break<\/strong><\/td>\r\n  <\/tr>\r\n\r\n  <tr class=\"panel-alt\">\r\n    <td><strong>10.00  - 11.00<\/strong><\/td>\r\n    <td><strong>The Assistants in Competetion <\/strong><br>\r\n      Moderator:  <strong><em>Ali \u0130hsan Ta\u015fc\u0131<\/em><\/strong><\/td>\r\n  <\/tr>\r\n\r\n  <tr class=\"session\">\r\n    <td><strong>11.00  - 12.00<\/strong><\/td>\r\n    <td><strong>Video Section<\/strong> - <strong>Rare  Surgical Procedures in Urology Practice<\/strong><br>\r\n      Moderators: <strong><em>Cahit  \u015eahin, Metin \u00d6zt\u00fcrk<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>11.00  - 11.15<\/td>\r\n    <td>Step-by-Step Intracorporeal Robotic Radical Cystectomy with Studer Pouch Reconstruction \/ <em><strong>Ya\u015far \u00d6zg\u00f6k<\/strong><\/em><strong><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>11.15  - 11.30<\/td>\r\n    <td>Robotic  bladder neck reconstruction \/<strong> <em>G\u00f6khan S\u00f6nmez<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>11.30  - 11.45<\/td>\r\n    <td>RPLND  \/ <strong><em>Ey\u00fcp Veli K\u00fc\u00e7\u00fck<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>11.45  - 12.00<\/td>\r\n    <td>Laparoscopic  Surrenalectomy \/ <strong><em>H\u00fcseyin \u00c7elik<\/em> <i class=\"fas fa-wifi\"><\/i><\/strong><\/td>\r\n  <\/tr>\r\n  <tr class=\"opening\">\r\n    <td><strong>12.00  - 12.30<\/strong><\/td>\r\n    <td><strong>Closing Ceremony<\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n<td>&nbsp;<\/td>\r\n    <td class=\"hallb\">HALL B<\/td>\r\n  <\/tr>\r\n  <tr class=\"kurs2\">\r\n    <td><strong>07.30  - 09.05<\/strong><\/td>\r\n    <td><strong>What  urologists should know about MpMRI: Masterclass Course<br>\r\n      <\/strong>Moderators: <strong><em>Atilla Semerci\u00f6z, Kerem Taken, Mehmet Zeynel Kesin<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>07.30  - 07.45<\/td>\r\n    <td>Scoring  system of PIRADS classification for urologists \/ <strong><em>R\u00fc\u015ft\u00fc T\u00fcrkay<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>07.45  - 08.00<\/td>\r\n    <td>Transperineal prostate biopsy performed under local anesthesia \/\r\n      <em><strong>Erdem \u00d6zt\u00fcrk<\/strong><\/em><strong><\/strong><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.00 - 08.15<\/td>\r\n    <td>Transperineal  fusion biopsy \/ <em><strong>Akif Erbin<\/strong><\/em><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.15  - 08.30<\/td>\r\n    <td>Robotic  fusion biopsy systems \/ <em><strong>Murat  Zor<\/strong><\/em><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.30  - 08.45<\/td>\r\n    <td>micro  usg f\u00fczyon kursu \/ <em><strong>Giray  Ergin<\/strong><\/em><\/td>\r\n  <\/tr>\r\n  <tr>\r\n    <td>08.45  - 09.05<\/td>\r\n    <td>Interactive  discussion \u2013 case <\/td>\r\n  <\/tr>\r\n  <tr class=\"oral\">\r\n    <td><strong>09.30 - 11.30<\/strong><\/td>\r\n    <td><strong>Oral Presentation 3<\/strong><br>\r\n      Moderators: <strong><em>Muzaffer Ak\u00e7ay, Ayhan Karak\u00f6se, Cabir Alan<\/em><\/strong><\/td>\r\n  <\/tr>\r\n  <tr class=\"oral-alt\">\r\n    <td>&nbsp;<\/td>\r\n    <td><table width=\"100%\" cellpadding=\"0\" cellspacing=\"0\" style=\"font-size: 10pt;\">\r\n   \r\n      <tr>\r\n        <td nowrap=\"nowrap\">SS-39<\/td>\r\n        <td>Parsiyel    Nefrektomi Uygulanan Hastalarda Postoperatif Komplikasyonlar\u0131n \u00d6ng\u00f6r\u00fclmesinde    Temas Y\u00fczey Alan\u0131n\u0131n Rol\u00fc<\/td>\r\n        <td>Mehmet Bu\u011fra    Mermer<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-40<\/td>\r\n        <td>\u00d6\u011frenme A\u015famas\u0131nda    HOLEP Cerrahisinde En-Blok ve Three-Lobe Tekni\u011fin Sonu\u00e7lar\u0131n\u0131n    Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<\/td>\r\n        <td>Yusuf Ar\u0131kan<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-41<\/td>\r\n        <td>Prognostic    Significance of Naples Prognostic Score in Patients with Testicular Germ Cell    Tumors: A Retrospective Analysis<\/td>\r\n        <td>Hakan Tekinaslan<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-42<\/td>\r\n        <td>\u00dcrolojik Kanser    Cerrahisinde Preoperatif Stres D\u00fczeylerinin Onkolojik Sonu\u00e7lara Etkisi:    Prospektif Bir Klinik \u00c7al\u0131\u015fma<\/td>\r\n        <td>Isa Kamil Tasdemir<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-43<\/td>\r\n        <td>Malign \u00fcreteral    obstruksiyon nedenli hidronefroz geli\u015fen hastalarda \u00fcreteral stent pasaj\u0131n\u0131    etkileyen fakt\u00f6rler<\/td>\r\n        <td>Mehmet Burak    Do\u011frusever<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-44<\/td>\r\n        <td>\u00dcroonkolojik    Cerrahide Taburculuk Saatinin Hasta Sonu\u00e7lar\u0131na Etkisi: Sirkadiyen Ritim    Perspektifinden 8 Y\u0131ll\u0131k Retrospektif Analiz<\/td>\r\n        <td>Isa Kamil Tasdemir<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-45<\/td>\r\n        <td>Relationship of Psoas    Muscle Index with Progression and Mortality in Patients Receiving Systemic    Chemotherapy for Testicular Germ Cell Tumors<\/td>\r\n        <td>Deniz Noyan \u00d6zl\u00fc<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-46<\/td>\r\n        <td>Ayn\u0131 Testiste Miks    Germ H\u00fccreli T\u00fcm\u00f6r \u0130le Ewing Sarkomu; Olgu Sunumu<\/td>\r\n        <td>H\u00fcseyin \u00c7elik<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-47<\/td>\r\n        <td>Benign veya Malign Nedenler Kaynakl\u0131 laparoskopik S\u00fcrrenalektomi Operasyoun Yap\u0131lan Hastalar\u0131n De\u011ferlendirilmesi, Bursa Uluda\u011f \u00dcniversitesi Deneyimi<\/td>\r\n        <td>Bertan Tanr\u0131buyurdu<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-48<\/td>\r\n        <td>\u00dcrolojik    Malignitelerin Ola\u011fan D\u0131\u015f\u0131 Metastazlar\u0131: Olgu Sunumu Serisi<\/td>\r\n        <td>K\u00fcr\u015fad D\u00f6nmez<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-49<\/td>\r\n        <td>Hospitalization due    to febrile urinary tract infection after prostate biopsy<\/td>\r\n        <td>Ilkin Ham\u0131d Zada<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-50<\/td>\r\n        <td>\u00dcrolojik Cerrahi    Sonras\u0131 Lenfosel Tedavisinde \u0130ntranodal Lenfanjiyografi ve Lenfatik    Embolizasyonun Yeri<\/td>\r\n        <td>Hasan Riza Aydin<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-51<\/td>\r\n        <td>Transrektal    Ultrasonografi E\u015fli\u011finde Prostat Biyopsisi Sonras\u0131 Enfeksiyon Geli\u015fen    Hastalarda Mikrobiyolojik Da\u011f\u0131l\u0131m ve Antibiyotik Direnci: Be\u015f Y\u0131ll\u0131k Tek    Merkez Deneyimi<\/td>\r\n        <td>Adem Utlu<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-52<\/td>\r\n        <td>Asemptomatik    mikroskopik hemat\u00fcrili hastalar\u0131n malignite a\u00e7\u0131s\u0131ndan de\u011ferlendirilmesi; Tek    merkez deneyimi<\/td>\r\n        <td>Ali Nihat G\u00f6kcan<\/td>\r\n      <\/tr>\r\n      <tr>\r\n        <td>SS-53<\/td>\r\n        <td>Avrupa \u00dcroloji    Derne\u011fi (EAU) Testis Kanseri Hasta Bilgilendirme Rehberi Bilgilendirme \u0130\u00e7in    Etkili ve Yeterli midir?<\/td>\r\n        <td>Emin G\u00fcrtan<\/td>\r\n      <\/tr>\r\n    <\/table><\/td>\r\n  <\/tr>\r\n  <\/table>\r\n\r\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3013806 elementor-widget elementor-widget-html\" data-id=\"3013806\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<script src=\"https:\/\/kit.fontawesome.com\/148b54e81e.js\" crossorigin=\"anonymous\"><\/script>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>16 May 2025 &#8211; Friday 17 May 2025 &#8211; Saturday 18 May 2025 &#8211; Sunday 19 May 2025 &#8211; Monday 16 May 2025 &#8211; Friday &nbsp; HALL A 13.00 &#8211; 15.00 Prostate cancer screening and diagnosis Moderators:Ali \u0130hsan Ta\u015f\u00e7\u0131, B\u00fclent G\u00fcnl\u00fcsoy, Hasan Bak\u0131rta\u015f 13.00 &#8211; 13.15 Current evidence and ongoing projects in screening programmes (OPT [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-48","page","type-page","status-publish","hentry"],"blocksy_meta":{"page_structure_type":"type-4","styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6}},"_links":{"self":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/pages\/48","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/comments?post=48"}],"version-history":[{"count":0,"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/pages\/48\/revisions"}],"wp:attachment":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/media?parent=48"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}